abstract |
FIELD: immunology. n SUBSTANCE: disclosed is a recovered human monoclonal antibody which binds to human MASP-2, as well as its antigen-binding fragment. Invention also discloses a nucleic acid coding molecule, an expression cassette, a cell and a method for producing an anti-MASP-2 antibody or an antigen-binding fragment thereof. Also described is a composition for treating a condition associated with MASP-2-dependent complement activation; use of an anti-MASP-2 antibody for preparing a drug and an industrial product for inhibiting MASP-2-dependent complement activation. n EFFECT: present invention can find further application in therapy of complement-mediated diseases. n 15 cl, 24 dwg, 30 tbl, 12 ex |